ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $42,000 | -99.5% | 447 | -99.7% | 0.00% | -100.0% |
| Q3 2021 | $7,756,000 | +6.3% | 130,249 | +21.8% | 0.07% | +9.5% |
| Q2 2021 | $7,294,000 | -3.4% | 106,949 | -1.7% | 0.06% | -10.0% |
| Q1 2021 | $7,550,000 | -4.5% | 108,803 | +5.7% | 0.07% | -15.7% |
| Q4 2020 | $7,906,000 | +0.3% | 102,897 | -2.4% | 0.08% | -19.4% |
| Q3 2020 | $7,882,000 | +16.8% | 105,385 | -1.7% | 0.10% | +8.4% |
| Q2 2020 | $6,747,000 | +18.6% | 107,188 | -20.9% | 0.10% | -5.0% |
| Q1 2020 | $5,688,000 | +4.0% | 135,428 | +12.5% | 0.10% | +37.0% |
| Q4 2019 | $5,467,000 | – | 120,363 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |